A. Krauss

发表

Clinical implications of immune reconstitution following hematopoietic stem cell transplantation.

K. Peggs, C. Mackall, A. Krauss, 2009, Cancer treatment and research.

Bone marrow transplantation for non‐malignant diseases using treosulfan‐based conditioning

M. Weintraub, I. Porat, P. Stepensky, 2015, Pediatric blood & cancer.

Effectiveness of long‐term routine pulmonary function surveillance following pediatric hematopoietic stem cell transplantation

S. Hananya, H. Mussaffi, D. Prais, 2014, Pediatric pulmonology.

Hematopoietic stem cell transplantation for pediatric autoimmune disease: where we stand and where we need to go

N. Kamani, N. Kamani, A. Krauss, 2009, Bone Marrow Transplantation.

FDA analysis of pembrolizumab trials in multiple myeloma: Immune related adverse events (irAEs) and response.

R. Pazdur, A. Rosenberg, R. Sridhara, 2018 .

Impact of Conditioning on Outcome of Hematopoietic Stem Cell Transplantation for Wiskott-Aldrich Syndrome

R. Elhasid, R. Somech, S. Revel-Vilk, 2013, Journal of pediatric hematology/oncology.

FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia

Jiang Liu, K. Goldberg, R. Pazdur, 2018, Clinical Cancer Research.

Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies.

J. Gribben, F. Cavalli, T. Habermann, 2018, The Lancet. Haematology.

Bispecific Antibodies and Other Non-CAR Targeted Therapies and HSCT: Decreased Toxicity for Better Transplant Outcome in Paediatric ALL?

J. Buechner, K. Kállay, M. Algeri, 2022, Frontiers in Pediatrics.

Pediatric myelodysplastic syndrome with inflammatory manifestations: Diagnosis, genetics, treatment, and outcome

S. Izraeli, H. Tamary, I. Geron, 2021, Pediatric blood & cancer.

Peripheral blood stem‐cell harvest using percutaneous arterial lines in children

I. Yaniv, J. Stein, E. Even-Or, 2013, Pediatric blood & cancer.

Val-BoroPro Accelerates T Cell Priming via Modulation of Dendritic Cell Trafficking Resulting in Complete Regression of Established Murine Tumors

T. Fry, S. Y. Kim, W. Bachovchin, 2013, PloS one.

Calcineurin inhibitor‐free strategies for prophylaxis and treatment of GVHD in children with posterior reversible encephalopathy syndrome after stem cell transplantation

I. Yaniv, J. Stein, O. Michaeli, 2017, Pediatric blood & cancer.

Second Hematopoietic Stem Cell Transplantation for Post-Transplantation Relapsed Acute Leukemia in Children: A Retrospective EBMT-PDWP Study.

I. Yaniv, B. Afanasyev, P. Bader, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pharmacologic modulation of niche accessibility via tyrosine kinase inhibition enhances marrow and thymic engraftment after hematopoietic stem cell transplantation.

C. Mackall, Natasha M. Fewkes, M. Guimond, 2010, Blood.